UNSPSC 51142570: Ropinirole hydrochloride

This classification denotes an antiparkinsonian agent with the molecular formula C16H24N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D7ZD41RZI9, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but more generally known as ropinirole hydrochloride, which bears US NIH Compound Identifier 5095. European Medicines Agency schedules Ropinirole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15144MIG.

Most nations, for tariff and trade purposes, schedule ropinirole hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, ROPINIROLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Ropinirole hydrochloride bears US NLM identifiers UMLS ID C0771840 and NCI Concept Code C47710. SMILES: CCCN(CCC)CCC1CCCC2C1CC(=O)N2.CL.

UNSPSC 51142570 Ropinirole hydrochloride is a Commodity code that in practice is being applied to state and local procurement of naloxone and drug deactivation systems for community health and public safety initiatives. The code's nominal scope—a pharmaceutical product for Parkinson's disease treatment—does not match the actual work being solicited under it in the recent state and local market. Seminole County, Florida tagged its naloxone and drug deactivation procurement under this code, indicating a mismatch between the taxonomy assignment and the goods actually being bought. State and local health departments and county public health agencies are the primary issuing bodies using this code to source emergency medical supplies and harm-reduction equipment rather than the specific pharmaceutical indicated by the code's name.

Seminole County, Florida remains the only recent issuing body with documented activity under this code in the current opportunities block. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 at 2:00 pm. The procurement is an IFB with a two-year initial term and one-year renewal option, vendors must comply with drug-free workplace and E-Verify requirements, and all shipping and delivery costs must be included in proposals. The mismatch between the code's pharmaceutical indication and the actual procurement scope suggests either a data-entry error in the county's tagging or a broader taxonomy misapplication; the code shows little relevant recent activity aligned with its stated commodity definition.